Private equity sells Obipektin and Overseal to Spanish biotech firm Private equity sells Obipektin and Overseal to Spanish biotech firm 12-May-2005 UK private equity firm 3i will shed food ingredients business Braes Group to Spanish biotech firm Natraceutical in a €80 million deal announced last week, reports Lindsey Partos.